A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis
- PMID: 33331988
- PMCID: PMC7745708
- DOI: 10.1007/s15010-020-01561-x
A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis
Abstract
Severe acute respiratory syndrome coronavirus 2 infection might induce a significant and sustained lymphopenia, increasing the risk of developing opportunistic infections. Mucormycosis is a rare but severe invasive fungal infection, mainly described in immunocompromised patients. The first case of a patient diagnosed with coronavirus disease (COVID-19) who developed a pulmonary mucormycosis with extensive cavitary lesions is here reported. This case highlights how this new coronavirus might impair the immune response, exposing patients to higher risk of developing opportunistic infections and leading to worse outcomes.
Keywords: Mucormycosis; Opportunistic infections; SARS-Cov-2.
© 2020. The Author(s).
Conflict of interest statement
All authors declare that they have no conflicts of interest.
Figures


Comment in
-
Mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum.Int J Surg. 2021 Aug;92:106031. doi: 10.1016/j.ijsu.2021.106031. Epub 2021 Jul 24. Int J Surg. 2021. PMID: 34311126 Free PMC article. No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous